These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 719249)

  • 1. Indomethacin and the hypotensive action of captopril in DOCA salt hypertensive rats [proceedings].
    Dollery CT; Miyamori I
    Br J Pharmacol; 1980 Jan; 68(1):117P-118P. PubMed ID: 6986936
    [No Abstract]   [Full Text] [Related]  

  • 2. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Water intake induced by isoprenaline in 2 models of experimental hypertension in rats].
    Vargas F; Casanova I; Fernández MA; Haro JM; García del Río C
    Rev Esp Fisiol; 1987 Dec; 43(4):395-9. PubMed ID: 3448705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
    Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
    Zicha J; Kunes J; Jelínek J
    Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOCA stimulates salt appetite in Zucker rats: effect of dose, synergistic action with central angiotensin II, and obesity.
    Omouessi ST; Falconetti C; Fernette B; Thornton SN
    Brain Res Bull; 2007 Sep; 74(1-3):14-20. PubMed ID: 17683784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
    Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K
    J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DOCA and salt intake on body sodium, fluid intake, blood pressure and excretion of a sodium load in rats.
    Simpson FO; Ledingham JM; Paulin JM; Purves RD
    J Hypertens Suppl; 1985 Dec; 3(3):S77-8. PubMed ID: 2856786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats.
    Elhaïmeur F; Courderot-Masuyer C; Nicod L; Bobillier-Chaumont S; Robin S; Richert L; Berthelot A
    Can J Physiol Pharmacol; 2003 May; 81(5):469-75. PubMed ID: 12774853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.
    Jin L; Beswick RA; Yamamoto T; Palmer T; Taylor TA; Pollock JS; Pollock DM; Brands MW; Webb RC
    J Physiol Pharmacol; 2006 Sep; 57(3):343-57. PubMed ID: 17033089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cardiovascular responsiveness to GABAergic stimulation in DOCA-salt hypertensive rats.
    Magrì V; Trimarchi GR; Quattrone G; Squadrito F; Di Giorgio RM; Costa G; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):107-18. PubMed ID: 6433410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsealed drug delivery systems I: In vitro-in vivo correlation on subcutaneous release of desoxycorticosterone acetate and prolonged hypertensive animal model for cardiovascular studies.
    Chien YW; Rozek LF; Lambert HJ
    J Pharm Sci; 1978 Feb; 67(2):214-7. PubMed ID: 621640
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of Aldactazide and DOCA injections on saline preference in Gerbils (Meriones unguiculatus).
    Wong R; Jones W
    Behav Biol; 1978 Aug; 23(4):460-8. PubMed ID: 697693
    [No Abstract]   [Full Text] [Related]  

  • 16. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1980 Dec; 20(6):409-52. PubMed ID: 7009133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the renin-angiotensin system in captopril-induced sodium appetite in the rat.
    Elfont RM; Epstein AN; Fitzsimons JT
    J Physiol; 1984 Sep; 354():11-27. PubMed ID: 6090647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies on angiotensin converting enzyme inhibitors.
    Natoff IL
    Cardiovasc Drugs Ther; 1987; 1(1):15-27. PubMed ID: 3154307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of SQ 14225 on fluid intake in DOCA/salt hypertensive rats [proceedings].
    Dean HG; Ingham S
    Br J Pharmacol; 1978 Nov; 64(3):390P-391P. PubMed ID: 719249
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.